ArticleBlood advances2023

Venetoclax-based therapies in pediatric advanced MDS and relapsed/refractory AML: a multicenter retrospective analysis.

Riccardo Masetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.